Virtu KCG Holdings’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-34,100
Closed -$2.87M 3285
2015
Q4
$2.87M Buy
34,100
+1,600
+5% +$133K 0.05% 275
2015
Q3
$2.72M Buy
32,500
+21,400
+193% +$1.81M 0.04% 293
2015
Q2
$927K Buy
11,100
+6,400
+136% +$488K 0.02% 913
2015
Q1
$341K Sell
4,700
-38,700
-89% -$2.76M 0.01% 1777
2014
Q4
$2.99M Buy
43,400
+14,000
+48% +$945K 0.05% 269
2014
Q3
$1.91M Sell
29,400
-300
-1% -$19K 0.04% 501
2014
Q2
$1.85M Sell
29,700
-17,500
-37% -$1.04M 0.03% 598
2014
Q1
$2.78M Buy
47,200
+12,400
+36% +$692K 0.03% 509
2013
Q4
$1.77M Buy
34,800
+400
+1% +$20K 0.02% 749
2013
Q3
$1.73M Buy
+34,400
New +$1.8M 0.02% 727

Other funds holding LLY

Virtu KCG Holdings's LLY Position: Q2 2017 in Review

Virtu KCG Holdings increased its Eli Lilly (LLY) stake by 263% in Q2 2017, buying an estimated $2.46M and bringing the position to 41,582 shares worth $3.42M. The position accounts for 0.1% of the portfolio, ranked #109.

Virtu KCG Holdings first reported a position in LLY in Q3 2013 and has held it in 15 quarters since. The position peaked at $5.32M in Q1 2015. 1,246 funds tracked by Wall St. Rank hold LLY as of Q2 2017.

  • Virtu KCG Holdings held 41,582 shares of Eli Lilly worth $3.42M as of Q2 2017.
  • Virtu KCG Holdings bought 30,114 Eli Lilly shares in Q2 2017, an estimated $2.46M.
  • Eli Lilly made up 0.1% of Virtu KCG Holdings's portfolio in Q2 2017, its #109 holding.
  • Virtu KCG Holdings first reported a position in Eli Lilly in Q3 2013 and has held it in 15 quarters since.
  • Virtu KCG Holdings's Eli Lilly position peaked at $5.32M in Q1 2015.
  • 1,246 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.